PAUCIS
PAUCIS offers a CD63+ exosome carrier platform emptied of native content and refilled with partner cargo for targeted delivery.
Visit paucis.bio ↗- Extension
- .bio
- Discovered
- 9/15/2026
- Domain registered
- Domain age
- Newly registered
- Language
- English
Why it's here
- ✓ The domain resolves and the homepage loads
- ✓ Not parked, for sale or a placeholder page
- ✓ Real content: at least 400 characters of text and several internal pages
- ✓ Passed an AI review for quality and safety
Why it ranks
24 Emerging
- Brand (25%)0
Not a known brand
- Popularity / traffic (20%)10
Not in Tranco top 1M
- Authority / backlinks (15%)unknown
Not checked yet
- Marketing of the domain (15%)45
Feasibility study offers, downloadable poster gate, clear technical brief
- Content quality (10%)78
78/100
- Design & build (5%)75
75/100
- Domain age (10%)1
0.1 years since registration
Detailed, professional biotech B2B landing page offering exosome drug delivery carrier services and feasibility studies.
More on .bio
Vir Biotechnology
Vir Biotechnology develops transformative antibody and immunology therapies for infectious diseases and cancer.
Kiro
A digital health platform providing clear, personalized analysis and tracking for laboratory and medical test results.
CSTI | Harvard Medical School
A research center at Harvard Medical School developing cell-based immunotherapies for brain tumors and metastatic cancers.